1. Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine Osteosarcoma. (2nd June 2016) Authors: Byrum, M.L.; Pondenis, H.C.; Fredrickson, R.L.; Wycislo, K.L.; Fan, T.M. Journal: Journal of veterinary internal medicine Issue: Volume 30:Number 4(2016:Jul./Aug.) Page Start: 1187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pro‐tumorigenic Effects of Transforming Growth Factor Beta 1 in Canine Osteosarcoma. (31st March 2014) Authors: Portela, R.F.; Fadl‐Alla, B.A.; Pondenis, H.C.; Byrum, M.L.; Garrett, L.D.; Wycislo, K.L.; Borst, L.B.; Fan, T.M. Journal: Journal of veterinary internal medicine Issue: Volume 28:Number 3(2014:May/Jun.) Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Association of Endothelin‐1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma. (1st October 2015) Authors: Neumann, Z.L.; Pondenis, H.C.; Masyr, A.; Byrum, M.L.; Wycislo, K.L.; Fan, T.M. Journal: Journal of veterinary internal medicine Issue: Volume 29:Number 6(2015:Nov./Dec.) Page Start: 1584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗